Anondita Medicare is engaged in the manufacturing of male condoms, offered in a variety of flavors, with its flagship product marketed under the brand “COBRA.” As certified by JP Sood, Chartered Engineer, on June 04, 2025, the Company has an installed production capacity of nearly 562 million condoms per annum. Its manufacturing facility, located at Sector 80, Noida, Uttar Pradesh, operates on sustainable practices by using CNG as a clean and environmentally friendly fuel in the production process.
Price Band₹137 - ₹145 |
Dates22 Aug - 26 Aug |
GMP₹86 (59.31%) |
Subscriptions301.28 times |
Issue Size₹69.50 Crs |
Price Band₹137 - ₹145 |
Listing AtNSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹69.50 Cr (0.48 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹69.50 Cr (0.48 Cr Shares) |
Face Value₹10 per equity share |
Investor Category | Lot | Shares | Amount | |
---|---|---|---|---|
Retail |
Minimum
1
1,000
1,45,000
Maximum
1
1,000
1,45,000
|
|||
Small HNI |
Minimum
2
2,000
2,90,000
Maximum
6
6,000
8,70,000
|
|||
Big HNI |
Minimum
7
7,000
10,15,000
|
Updated as on 26-Aug-2025 19:00:42 hrs
Investor Category | Subscription (times) | Shares Offered | Shared Bid |
---|---|---|---|
QIB | 153.03 | 9,06,000 | 13,86,48,000 |
NII | 532.25 | 6,81,000 | 36,24,63,000 |
bNII | - | 0 | 29,12,93,000 |
sNII | - | 0 | 7,11,70,000 |
Retail | 286.77 | 15,84,000 | 45,42,42,000 |
Total | 301.28 | 31,71,000 | 95,53,53,000 |
The estimated Grey Market Premium of Anondita Medicare IPO is ₹86 per share (59.31%)
Particulars | Allocation |
---|---|
QIB | Not more than 50% of Net Offer |
NII | Not less than 15% of Net Offer |
Retail | Not less than 35% of Net Offer |
Market Maker | 270000 EQ Shares |
Employee | - |
Shareholder | - |
Particulars | Mar-25 | Mar-24 | Mar-23 |
---|---|---|---|
Revenue from Operations | 76.99 | 46.43 | 35.91 |
Profit after Tax | 16.42 | 3.84 | 0.35 |
Net Worth | 37.87 | 10.59 | 8.69 |
Total Borrowing | 27.39 | 24.01 | 22.66 |
Total Assets | 64.28 | 42.92 | 37.80 |
NAV per share (in ₹) | 28.49 | - | - |
EPS - Basic (in ₹) | 14.04 | - | - |
The financial information presented is on a consolidated basis
KPI | Values |
---|---|
EBITDA | 33.32% |
PAT | 17.85% |
ROE | 41.71% |
ROCE | 37.42% |
PE Ratio | 10.33 |
PB Ratio | 5.09 |
Mkt Cap (in Crs.) | 262.26 |
Particulars | Anondita Medicare | Cupid |
---|---|---|
Revenue from Ops (in Crs.) | 60.52 | 183.25 |
PAT (In Crs.) | 10.80 | 40.93 |
EPS - Basic | 9.60 | 1.52 |
NAV per share | 21.32 | 12.75 |
RONW | 38.10% | 11.96% |
EBITDA | 29.55% | 22.79% |
PAT Margin | 17.85% | 22.34% |
Price to earning (PE) | 10.33 | 110.38 |
Particulars | Anondita Medicare |
---|---|
Revenue from Ops (in Crs.) | 60.52 |
PAT (In Crs.) | 10.80 |
EPS - Basic | 9.60 |
NAV per share | 21.32 |
RONW | 38.10% |
EBITDA | 29.55% |
PAT Margin | 17.85% |
Price to earning (PE) | 10.33 |
Cupid |
---|
183.25 |
40.93 |
1.52 |
12.75 |
11.96% |
22.79% |
22.34% |
110.38 |
Name | B |
---|---|
Anupam Ghosh | 83.95% |
Total | 83.95% |
Name | Designation |
---|---|
Anupam Ghosh | MD |
Sunita Naithani | CFO |
Name: Anondita Medicare Limited
Address: Flat No.704 Narmada Block, N6, Sec-D, Pkt-6 Vasant Kunj, New Delhi, India-110070.
Number: +91 7678182056
Email: info@anonditamedicare.com
Website: www.anonditamedicare.com
Find answers to common questions that come in your mind related to IPO.
Anondita Medicare IPO is a SME IPO having an issue size of Rs. ₹69.50 Crs. Anondita Medicare IPO is priced at ₹137 - ₹145 per share. The issue opens on 22 Aug 25 and closes on 26 Aug 25.
Anondita Medicare IPO opens on 22 Aug 25 and closes on 26 Aug 25.
The estimated Grey Market Premium of Anondita Medicare IPO is ₹86 per share (59.31%).
The minimum lot size of Anondita Medicare IPO is 1000 shares & the minimum application amount is Rs. 145000.
The allotment date of Anondita Medicare IPO is 28 Sep 25.
The listing date of Anondita Medicare IPO is 01 Sep 25.
Anondita Medicare IPO is subscribed 301.28 times.
Anondita Medicare IPO is priced at ₹137 - ₹145 per share.
Click the allotment link on Anondita Medicare IPO page of IPO360.